Results 11 to 20 of about 7,148 (200)
Medication Overuse Headache [PDF]
Continuum, 2017 Medication-overuse headache (MOH) has been described for almost 100 years and is characterized as a daily or near-daily headache that usually presents in patients with preexisting primary headache disorders who are overusing one or more acute or symptomatic headache medications. This article reviews the diagnosis and management of patients with MOH.The
Louter, M.A. +2 more
+8 more sources
Headache Medicine, 2023 Migraine is a common, highly prevalent genetic neurological disorder. Its most burdensome form is the chronic migraine, which is clinically defined by the presence of headache on ≥15 days/month for longer than three months, with eight or more typical ...
Carla Jevoux +4 more
doaj +1 more source
Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
Neurological Research and Practice, 2022 Introduction Chronic headache due to the overuse of medication for the treatment of migraine attacks has a prevalence of 0.5–2.0%. This guideline provides guidance for the management of medication overuse (MO) and medication overuse headache (MOH ...
Hans-Christoph Diener +11 more
doaj +1 more source
Evaluation and treatment of medication-overuse headache: Russian experts’ guidelines
Неврология, нейропсихиатрия, психосоматика, 2022 The Russian experts’ guidelines on evaluation and treatment of medication-overuse headache are based on evidence-based medicine, the latest revision of the International Classification of Headache Disorders.
G. R. Tabeeva +16 more
doaj +1 more source
BMC Geriatrics, 2022 Background Although headache is a common complaint in younger individuals, it is one of the most common complaints among persons over the age of 50 and is a significant cause of morbidity. As there are differences in the causes and types of headache, the
Mansoureh Togha +8 more
doaj +1 more source
Predictors of response to erenumab after 12 months of treatment
Brain and Behavior, 2021 Objective Erenumab is a monoclonal antibody acting against calcitonin gene‐related peptide receptor and approved for the preventive treatment of chronic migraine.
Carlo Baraldi +4 more
doaj +1 more source
Research progress of medication⁃overuse headache
Chinese Journal of Contemporary Neurology and Neurosurgery, 2022 Medication⁃overuse headache (MOH) is a global public health problem involving medicine, economics and sociology. High frequency or chronic primary headache is a risk factor of MOH. The methods to prevent MOH are to strengthen the treatment and management
CHEN Chun⁃fu
doaj +1 more source
Medication-overuse headache [PDF]
Canadian Medical Association Journal, 2018 Patients with primary headache disorders who overuse analgesia are at risk for MOH, in which the analgesia leads to the paradoxical effect of increasing headache frequency ([Box 1][1]).[1][2] The prevalence of MOH in the general population is 1%–2% and as high as 20.6% in referrals to ...
Andrew, Micieli, Jennifer, Robblee
openaire +2 more sources
Medication-overuse headache: a widely recognized entity amidst ongoing debate
The Journal of Headache and Pain, 2018 Medication overuse in primary headache disorders is a worldwide phenomenon and has a role in the chronification of headache disorders. The burden of disease on individuals and societies is significant due to high costs and comorbidities.
Nicolas Vandenbussche +10 more
doaj +1 more source
A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities
Brain Sciences, 2023 Purpose of review: Medication-overuse headache (MOH) is an important problem worldwide, with different areas of controversy regarding its entity. This article reviews the risk factors, comorbidities, pathophysiology, clinical presentation, effective ...
Srdjan Ljubisavljevic +3 more
doaj +1 more source